课题基金 / 基金详情

Training in Systems Pharmacology and Toxicology (T-SPaT)

Training in Systems Pharmacology and Toxicology (T-SPaT)
系统药理学和毒理学培训 (T-SPaT)
批准号:
10714918
负责人:
Paul L Prather
金额:
$17.4万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-01 至 2028-06-30

项目摘要

项目成果

Paul L Prather的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结/摘要 在过去的几十年里,我们对细胞与药物和毒素相互作用的机制的了解, 由于新的分子分析技术和基因组学方法的应用,因此 药理学和毒理学学科研究生教育的重点需要从 简化论者认为,系统的方法,其中博士生得到全面的培训,使他们能够 制定解决重要生物学问题的战略,不仅在分子、细胞和组织水平上 而且是在整个动物的水平上。系统药理学和毒理学描述了一个研究领域, 对毒品作用的广泛看法。使用体内动物模型的系统方法对于建立功效是必要的, 候选药物的安全性和药效学/药代动力学特征,但学生短缺 在这方面受过训练。本系统药理学和毒理学培训(T-SPaT)计划旨在 博士生在他们的研究生学习的第二年追求论文研究项目, 药理学培训生(2/年,最多支持2年)和33名计划教师来自 跨学科生物医学科学研究生课程(GPIBS)和MD/PhD课程。T-SPaT 该计划将培训学生使用体内方法来回答药理学中的相关问题, 毒理学,重点是代谢,药物设计,药效学,药代动力学和信号。 T-SPaT计划的基本原理是,这种类型的培训将为学生提供更广泛的 药理学和毒理学的观点,这将更好地为他们进行安全,道德和严格的 作为药理学领域多学科研究团队的领导者,我们将整合T- SPaT到博士培训计划已经活跃在我们的研究生培训地点在小石城地区,其中包括 阿肯色州UAMS的医学、药学和公共卫生学院的教师/科学家 儿童医院校园,并在食品和药物管理局资助的国家毒理学中心 Research. T-SPaT的独特重点是体内系统药理学和毒理学培训 方法和概念。T-SPaT的目的是提供体内药理学和毒理学培训 补充学生在家庭课程中接受的细胞和分子训练。培训 该计划包括药理学,毒理学,生理学,药代动力学,代谢, 生物统计学,赠款写作,以及研究的负责任行为沿着实验室研究使用在 人类疾病的体内模型。T-SPaT计划还将提供强有力的指导,广泛的网络, 并通过其方案活动为学员提供教学和领导机会。
英文摘要
PROJECT SUMMARY/ABSTRACT Over the past few decades, our knowledge of the mechanisms by which cells interact with drugs and toxins has exploded due to new molecular analysis techniques and the application of genomic methods. Accordingly, the emphasis of graduate education in the disciplines of pharmacology and toxicology needs to shift from a reductionist view to a systems approach in which doctoral students are comprehensively trained so they can formulate a strategy to solve important biological questions not only at the molecular, cellular, and tissue levels but also at the whole-animal level. Systems pharmacology and toxicology describes a field of study that considers the broad view of drug action. A systems approach using in vivo animal models is necessary to establish efficacy, safety and the pharmacodynamic/pharmacokinetic profile of candidate drugs but there is a shortage of students trained in this area. This Training in Systems Pharmacology and Toxicology (T-SPaT) Program is designed for PhD students in their second year of graduate study pursuing dissertation research projects in the pharmacological sciences. Trainees (2/year for up to 2 years of support) and 33 Program faculty are drawn from the Graduate Program in Interdisciplinary Biomedical Sciences (GPIBS) and the MD/PhD Program. The T-SPaT program will train students to use an in vivo approach to answering relevant questions in pharmacology and toxicology with emphasis on metabolism, drug design, pharmacodynamics, pharmacokinetics, and signaling. The rationale for the T-SPaT program is that this type of training will provide students with a much broader perspective on pharmacology and toxicology that will better prepare them to conduct safe, ethical and rigorous research as leaders of multidisciplinary research teams in the pharmacological sciences. We will integrate T- SPaT into PhD training programs already active at our graduate training sites in the Little Rock area that include faculty/scientists in the Colleges of Medicine, Pharmacy, and Public Health on the UAMS, the Arkansas Children’s Hospital campus, and at the Food and Drug Administration-funded National Center for Toxicological Research. The unique focus of T-SPaT is training with in vivo systems pharmacological and toxicological approaches and concepts. The objective of T-SPaT is to provide in vivo pharmacology and toxicology training that complement the cellular and molecular training that students receive in their home programs. The training program consists of didactic training in pharmacology, toxicology, physiology, pharmacokinetics, metabolism, biostatistics, grant writing, and the Responsible Conduct of Research along with laboratory research using an in vivo model of human disease. The T-SPaT program will also provide strong mentoring, extensive networking, and teaching and leadership opportunities for its trainees through its programmatic activities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Synthetic Cannabinoid Toxicity: Role of Biotransformation
  • 批准号:
    9520656
  • 项目类别:
  • 资助金额:
    $4.35万
  • 财政年份:
    2016
  • 负责人:
    Paul L Prather
  • 依托单位:
Synthetic Cannabinoid Toxicity: Role of Biotransformation
  • 批准号:
    9914444
  • 项目类别:
  • 资助金额:
    $4.35万
  • 财政年份:
    2016
  • 负责人:
    Paul L Prather
  • 依托单位:
Synthetic Cannabinoid Toxicity: Role of Biotransformation
  • 批准号:
    9037178
  • 项目类别:
  • 资助金额:
    $54.97万
  • 财政年份:
    2016
  • 负责人:
    Paul L Prather
  • 依托单位:
Synthetic Cannabinoid Toxicity: Role of Biotransformation
  • 批准号:
    9272377
  • 项目类别:
  • 资助金额:
    $53.97万
  • 财政年份:
    2016
  • 负责人:
    Paul L Prather
  • 依托单位:
国内基金
海外基金
基于铁死亡探讨黄芪甲苷调控System/Xc-/GSH/GPX4信号通路在神经损伤性勃起功能障碍治疗中的作用及机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    马轲
  • 依托单位:
System Xc-/GSH/GPX4铁死亡通路介导的枸杞多糖对全氟辛酸致仔鼠肾损伤的保护机制
  • 批准号:
    32573411
  • 项目类别:
    面上项目
  • 资助金额:
    51.00万元
  • 批准年份:
    2025
  • 负责人:
    王晓丹
  • 依托单位:
Data-driven Recommendation System Construction of an Online Medical Platform Based on the Fusion of Information
TBX1/LKB1轴阻断system Xc活性调控AML细胞铁死亡的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
  • 依托单位: